A double blind, randomized, placebo controlled clinical study evaluates the early efficacy of aflapin in subjects with osteoarthritis of knee.

Aflapin supplementation for 30 days afforded highly significant (p<0.001) reductions in all the pain scores exhibiting 49.1, 34.4, 49.5, 48.4 and 45.2 percent reduction, in VAS, LFI, WOMAC pain, WOMAC stiffness and WOMAC function scores, respectively, when compared to the baseline.

also in 132,142 other papers